Skip to Main Content

Paper Details

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
J Natl Cancer Inst
10
2023
Author NameAffiliation
Todd A AlonzoKeck School of Medicine, University of Southern California
Todd A AlonzoKeck School of Medicine, University of Southern California
Nilsa C RamirezResearch Institute at Nationwide Children's Hospital
Douglas S HawkinsSeattle Children's Hospital, University of Washington
Katherine A JanewayHarvard Medical School
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
  • 1 - 7

Datasets

Release 1.2